Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$30.16 -0.4%	$30.78	$26.25 ▼ $40.49	$15.48B	0.63	4.49 million shs	2.10 million shs
MASI Masimo	$150.13 +0.1%	$158.42	$101.61 ▼ $194.88	$8.14B	1.23	651,566 shs	311,070 shs
PODD Insulet	$321.36 +0.1%	$271.13	$171.61 ▼ $329.33	$22.62B	1.26	708,726 shs	693,216 shs
STE STERIS	$243.21 -0.2%	$226.25	$200.98 ▼ $252.79	$23.90B	0.96	543,647 shs	538,496 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	0.00%	-4.80%	-0.80%	-10.95%	-12.21%
MASI Masimo	0.00%	-3.53%	-7.69%	-11.67%	+18.59%
PODD Insulet	0.00%	-1.04%	+23.90%	+13.64%	+77.47%
STE STERIS	0.00%	-3.53%	+7.39%	+10.33%	+5.47%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAX Baxter International	4.574 of 5 stars	3.2	3.0	1.7	4.0	2.0	1.7	2.5
MASI Masimo	4.8429 of 5 stars	4.4	3.0	0.0	4.2	3.6	3.3	1.3
PODD Insulet	4.4308 of 5 stars	2.4	5.0	0.0	4.9	4.1	0.8	1.9
STE STERIS	4.4977 of 5 stars	2.4	5.0	3.3	3.8	2.9	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.44	Hold	$37.25	23.52% Upside
MASI Masimo	2.83	Moderate Buy	$191.60	27.62% Upside
PODD Insulet	2.82	Moderate Buy	$308.00	-4.16% Downside
STE STERIS	2.71	Moderate Buy	$264.00	8.55% Upside

Current Analyst Ratings Breakdown

Latest MASI, STE, PODD, and BAX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	PODD Insulet	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$320.00 ➝ $380.00
5/19/2025	STE STERIS	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$240.00 ➝ $260.00
5/16/2025	PODD Insulet	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
5/16/2025	STE STERIS	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
5/16/2025	STE STERIS	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$265.00 ➝ $280.00
5/15/2025	STE STERIS	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$250.00 ➝ $250.00
5/13/2025	PODD Insulet	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Peer Perform ➝ Outperform	$350.00
5/9/2025	PODD Insulet	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$312.00 ➝ $324.00
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00

(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$10.77B	1.44	$4.68 per share	6.45	$16.69 per share	1.81
MASI Masimo	$2.13B	3.83	$4.88 per share	30.74	$25.79 per share	5.82
PODD Insulet	$2.20B	10.29	$4.23 per share	75.96	$10.49 per share	30.63
STE STERIS	$5.46B	4.38	$15.46 per share	15.73	$65.43 per share	3.72

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$649M	-$1.10	N/A	11.05	0.93	-5.05%	16.67%	4.93%	8/5/2025 (Estimated)
MASI Masimo	$81.50M	-$9.17	103.54	32.43	N/A	3.85%	14.98%	6.95%	8/5/2025 (Estimated)
PODD Insulet	$206.30M	$5.56	55.50	64.66	3.62	20.19%	24.46%	8.33%	N/A
STE STERIS	$378.24M	$6.20	51.64	24.49	N/A	8.66%	13.91%	8.64%	8/5/2025 (Estimated)

Latest MASI, STE, PODD, and BAX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q4 2025	STE STERIS	$2.59	$2.74	+$0.15	$1.47	$1.47 billion	$1.48 billion
5/8/2025	Q1 2025	PODD Insulet	$0.81	$1.02	+$0.21	$0.50	$543.20 million	$569.00 million
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
5/1/2025	Q1 2025	BAX Baxter International	$0.48	$0.62	+$0.14	$0.25	$2.59 billion	$2.63 billion
2/25/2025	Q4 2024	MASI Masimo	$1.42	$1.80	+$0.38	-$6.52	$593.35 million	$600.70 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.68	2.25%	-1.40%	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.28	0.94%	+9.51%	36.77%	20 Years

Latest MASI, STE, PODD, and BAX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2025	BAX Baxter International	quarterly	$0.17	2.27%	5/30/2025	5/30/2025	7/1/2025
5/7/2025	STE STERIS	quarterly	$0.57	1.01%	6/10/2025	6/10/2025	6/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.31	1.43	1.09
MASI Masimo	0.50	2.01	1.11
PODD Insulet	1.21	3.68	2.80
STE STERIS	0.32	2.13	1.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
MASI Masimo	85.96%
PODD Insulet	N/A
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.21%
MASI Masimo	16.90%
PODD Insulet	0.39%
STE STERIS	1.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	60,000	513.18 million	509.47 million	Optionable
MASI Masimo	6,200	54.22 million	48.35 million	Optionable
PODD Insulet	2,600	70.38 million	69.82 million	Optionable
STE STERIS	16,000	98.25 million	97.13 million	Optionable

MASI, STE, PODD, and BAX Headlines

Recent News About These Companies

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in STERIS plc (NYSE:STE)

May 25 at 5:07 AM | marketbeat.com

STERIS plc (NYSE:STE) Shares Sold by USS Investment Management Ltd

May 25 at 4:55 AM | marketbeat.com

Worldquant Millennium Advisors LLC Sells 23,001 Shares of STERIS plc (NYSE:STE)

May 25 at 4:54 AM | marketbeat.com

Two Sigma Advisers LP Acquires Shares of 45,547 STERIS plc (NYSE:STE)

May 25 at 4:33 AM | marketbeat.com

Royal Bank of Canada Has $34.38 Million Holdings in STERIS plc (NYSE:STE)

May 25 at 4:13 AM | marketbeat.com

STERIS plc (NYSE:STE) Receives Average Rating of "Moderate Buy" from Brokerages

May 25 at 1:47 AM | marketbeat.com

STERIS (NYSE:STE) Rating Increased to Strong-Buy at Wall Street Zen

May 24 at 11:46 AM | marketbeat.com

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 84,310 Shares of STERIS plc (NYSE:STE)

May 24 at 5:57 AM | marketbeat.com

Cetera Investment Advisers Has $1.43 Million Holdings in STERIS plc (NYSE:STE)

May 24 at 3:38 AM | marketbeat.com

Twinbeech Capital LP Grows Holdings in STERIS plc (NYSE:STE)

May 23 at 5:57 AM | marketbeat.com

Two Sigma Investments LP Buys 117,404 Shares of STERIS plc (NYSE:STE)

May 23 at 5:37 AM | marketbeat.com

Nomura Holdings Inc. Invests $669,000 in STERIS plc (NYSE:STE)

May 23 at 4:10 AM | marketbeat.com

Williams Jones Wealth Management LLC. Sells 29,200 Shares of STERIS plc (NYSE:STE)

May 22 at 6:18 AM | marketbeat.com

Rafferty Asset Management LLC Boosts Holdings in STERIS plc (NYSE:STE)

May 22 at 4:56 AM | marketbeat.com

ProShare Advisors LLC Purchases 3,685 Shares of STERIS plc (NYSE:STE)

May 22 at 4:35 AM | marketbeat.com

Are Options Traders Betting on a Big Move in STERIS (STE) Stock?

May 21, 2025 | msn.com

AST Business Growth & Strategic Acquisitions Support STERIS Stock

May 21, 2025 | zacks.com

Is it the Right Time to Hold STERIS Stock in Your Portfolio?

May 21, 2025 | zacks.com

32,909 Shares in STERIS plc (NYSE:STE) Acquired by Sone Capital Management LLC

May 21, 2025 | marketbeat.com

Strategic Wealth Partners Ltd. Decreases Holdings in STERIS plc (NYSE:STE)

May 21, 2025 | marketbeat.com

1,117 Shares in STERIS plc (NYSE:STE) Bought by NorthRock Partners LLC

May 21, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
By Nathan Reiff | April 30, 2025
View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
Buybacks and Big-Time Developments: 3 Stocks Making Huge Moves
By Leo Miller | May 19, 2025
View Buybacks and Big-Time Developments: 3 Stocks Making Huge Moves
After Earnings Beats, These 3 Stocks Are on Analysts’ Radars
By Leo Miller | May 20, 2025
View After Earnings Beats, These 3 Stocks Are on Analysts’ Radars
3 Mid-Cap Stocks Turning Heads in AI, Automation, & Cybersecurity
By Nathan Reiff | May 16, 2025
View 3 Mid-Cap Stocks Turning Heads in AI, Automation, & Cybersecurity
Amazon: Why May Is the Last Month to Get the Stock at a Discount
By Sam Quirke | May 19, 2025
View Amazon: Why May Is the Last Month to Get the Stock at a Discount

MASI, STE, PODD, and BAX Company Descriptions

Baxter International NYSE:BAX

$30.16 -0.11 (-0.38%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$30.32 +0.17 (+0.56%)

As of 05/23/2025 07:57 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Masimo NASDAQ:MASI

$150.13 +0.22 (+0.15%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$148.48 -1.66 (-1.10%)

As of 05/23/2025 05:27 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Insulet NASDAQ:PODD

$321.36 +0.36 (+0.11%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$322.26 +0.89 (+0.28%)

As of 05/23/2025 06:49 PM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS NYSE:STE

$243.21 -0.59 (-0.24%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$242.96 -0.24 (-0.10%)

As of 05/23/2025 04:14 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time